Dermata Therapeutics Inc.
Organization details
- Legal name
- Dermata Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- SAN Diego
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- DRMA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001853816
Board of directors
-
Andrew Seth Sandler · DirectorSince 2024
-
Brittany Bradrick · DirectorSince 2024
-
David F. Hale · DirectorSince 2024
-
Gerald T. Proehl · Director · PRESIDENT, CHAIRMAN, CEOSince 2024
-
Kathleen D. Scott · DirectorSince 2024
-
Mary Fisher · DirectorSince 2024
-
Steven J. Mento · DirectorSince 2024
-
Wendell Wierenga · DirectorSince 2024
Chief executives
Director election results
Annual meeting of May 27, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
96.4%
-
96.4%
-
96.7%
Board connections
2 of this board's directors also sit on 2 other boards. 2 are in the same sector.
-
Cytokinetics Incorporated Same sectorvia Wendell Wierenga
-
Tenax Therapeutics Inc. Same sectorvia Gerald T. Proehl
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $1,270
- 1 purchase by 1 insider
- Sold, last 12 months
- $13
- 1 sale by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 16, 2026 | Van Hoose Kyri K. Officer (SVP, CFO) | Grant or award | +102,040 | — | — |
| Aug 16, 2026 | Gerald T. Proehl Director, Officer (PRESIDENT, CHAIRMAN, CEO), 10% owner | Grant or award | +170,068 | — | — |
| Jun 16, 2026 | Kathleen D. Scott Director | Open-market sale | −11 | $1.19 | $13 |
| Feb 17, 2026 | Bedoya-Toro Munera Maria E Officer (SVP, Regulatory Affairs) | Open-market purchase | +1,000 | $1.27 | $1,270 |
| Dec 23, 2025 | Van Hoose Kyri K. Officer (SVP, CFO) | Grant or award | +122,549 | — | — |
| Dec 23, 2025 | Gerald T. Proehl Director, Officer (PRESIDENT, CHAIRMAN, CEO), 10% owner | Grant or award | +490,196 | — | — |
| Dec 23, 2025 | Gerald T. Proehl Director, Officer (PRESIDENT, CHAIRMAN, CEO), 10% owner | Grant or award | +122,549 | — | — |
| Jan 23, 2025 | David F. Hale Director | Grant or award | +78,741 | — | — |
| Jan 21, 2025 | Mary Fisher Director | Grant or award | +196,851 | — | — |
| Jan 21, 2025 | Van Hoose Kyri K. Officer (SVP, CFO) | Grant or award | +78,741 | — | — |
| Jan 21, 2025 | Gerald T. Proehl Director, Officer (President, CEO and Chairman), 10% owner | Grant or award | +787,402 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Dermata Therapeutics Inc.
Who is the CEO of Dermata Therapeutics Inc.?
Gerald T. Proehl is Dermata Therapeutics Inc.'s President, CEO and Chairman.
How many directors are on Dermata Therapeutics Inc.'s board?
Dermata Therapeutics Inc.'s board has 8 directors: Andrew Seth Sandler, Brittany Bradrick, David F. Hale, Gerald T. Proehl, Kathleen D. Scott, Mary Fisher, Steven J. Mento and Wendell Wierenga.
Are Dermata Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Dermata Therapeutics Inc. insiders bought $1,270 of shares in 1 purchase and sold $13 of shares in 1 sale on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="dermata-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.